![]() |
Anatomy and Physiology Saladin | |||||
|---|---|---|---|---|---|---|
| Student
Online Learning Center |
||||||
|
Selected Vocabulary |
Chapter 21: The Lymphatic and Immune Systems |
term |
page reference |
lymphatic system |
755 |
lymph |
755 |
lymphatic capillary |
755 |
collecting vessel |
756 |
lymphatic trunk |
757 |
collecting duct |
757 |
right lymphatic duct |
757 |
thoracic duct |
757 |
cisterna chyli |
757 |
diffuse lymphatic tissue |
758 |
mucosa-associated lymphatic tissue (MALT) |
758 |
lymphatic nodule |
758 |
Peyer patches |
760 |
lymph node |
760 |
germinal center |
760 |
afferent lymphatic vessel |
760 |
efferent lymphatic vessel |
760 |
tonsils |
762 |
tonsillar crypts |
762 |
palatine tonsil |
762 |
lingual tonsil |
762 |
pharyngeal tonsil |
762 |
thymus |
762 |
involution |
762 |
thymopoietin |
762 |
thymosin |
762 |
spleen |
762 |
red pulp |
762 |
white pulp |
762 |
nonspecific resistance |
764 |
immunity |
764 |
lysozyme |
765 |
phagocyte |
765 |
killing zone |
765 |
degranulation |
765 |
respiratory burst |
765 |
natural killer (NK) cell |
765 |
macrophage system |
765 |
histiocyte |
765 |
inflammation |
765 |
cardinal signs |
766 |
inflammatory chemicals |
766 |
bradykinin |
766 |
margination |
767 |
diapedesis |
767 |
chemotaxis |
767 |
leukocytosis-promoting factor |
767 |
pus |
767 |
platelet-derived growth factor (PDGF) |
768 |
interferon |
768 |
complement system |
768 |
classical pathway |
768 |
complement fixation |
768 |
alternate pathway |
768 |
opsonization |
768 |
cytolysis |
768 |
fever |
768 |
pyrogen |
768 |
immune system |
771 |
humoral immunity |
771 |
cellular immunity |
771 |
antigen (Ag) |
772 |
antigenic determinant |
772 |
hapten |
772 |
antibody (Ab) |
772 |
antibody monomer |
772 |
heavy chain |
772 |
light chain |
772 |
variable region |
772 |
antigen-binding site |
772 |
constant region |
773 |
IgA, IgD, IgE, IgG, IgM |
773 |
passive immunity |
773 |
active immunity |
773 |
T lymphocyte |
773 |
B lymphocyte |
773 |
immunocompetent |
774 |
clone |
774 |
virgin lymphocyte pool |
774 |
clonal deletion |
774 |
self-tolerance |
774 |
antigen-presenting cell (APC) |
774 |
interleukin |
774 |
lymphokine |
774 |
monokine |
774 |
capping |
775 |
antigen display |
775 |
MHC protein |
775 |
immunological surveillance |
775 |
helper factor |
776 |
clonal selection |
776 |
plasma cell |
776 |
somatic recombination |
777 |
neutralization |
777 |
agglutination |
778 |
precipitation |
778 |
primary immune response |
779 |
antibody titer |
779 |
memory cell |
779 |
secondary (anamnestic) immune response |
779 |
cytotoxic T cell |
780 |
helper T cell |
780 |
suppressor T cell |
780 |
memory T cell |
780 |
MHC-I and MHC-II proteins |
780 |
MHC restriction |
780 |
costimulation |
780 |
macrophage-activating factor (MAF) |
781 |
lethal hit |
781 |
perforin |
781 |
lymphotoxin |
782 |
tumor necrosis factor (TNF) |
782 |
migration-inhibiting factor (MIF) |
782 |
T cell recall response |
783 |
hypersensitivity |
784 |
allergen |
784 |
type I hypersensitivity |
784 |
anaphylaxis |
785 |
asthma |
785 |
anaphylactic shock |
785 |
type II hypersensitivity |
785 |
type III hypersensitivity |
785 |
type IV hypersensitivity |
785 |
autoimmune disease |
785 |
autoantibody |
785 |
severe combined immunodeficiency disease (SCID) |
786 |
acquired immunodeficiency syndrome (AIDS) |
787 |
human immunodeficiency virus (HIV) |
787 |
MHHE Home | About MHHE | Help Desk | Legal Policies and Info | Order Info | What's New | Get Involved